Professor Gavin Wilkinson
Projects as PI
- Analysis of cytomegalovirus pathogenesis in a human challenge system (01/04/2018 - 03/04/2023)
- An analysis of wild type human cytomegalovirus (01/12/2010 - 08/05/2014)
- A systematic investigation into human cytomegalovirus gene function (08/05/2014 - 31/12/2017)
- Development of a cytomegalovirus-based 5T4-expressing cancer vaccine (01/07/2015 - 30/06/2016)
- Development of adenovirus type 4 vectors for immunotherapeutic application (01/10/2008 - 31/01/2012)
Projects as Co-Investigator
- Designing unconventional peptide modifications to universally enhance cd4+ t-cell activation (08/05/2018 - 08/05/2024)
- Developing HCMV as a vaccine vector (01/01/2014 - 31/12/2016)
- Developing HCMV as a vaccine vector (01/10/2017 - 31/10/2018)
- Development of adenovirus serotype 49 for cancer virotherapy applications (01/10/2015 - 30/09/2019)
- Development of anti-viral immunotherapy (01/10/2017 - 31/03/2018)